Revenue Cycle Quality Emerges as Key Valuation Driver in Physician Practice M&A

According to a recent LinkedIn post from CERTIFY Pay, physician practice M&A activity remained active in Q1 2026, with 79 transactions reported and EBITDA multiples in the high single to low double digits across cardiology, gastroenterology, and orthopedics. The post suggests that while headline valuation ranges are stable, the mechanics behind how those multiples are underwritten are shifting toward deeper scrutiny of revenue cycle performance.

The company’s LinkedIn post highlights that buyers are increasingly validating denial rates, charge capture accuracy, payer mix consistency, and supporting documentation rather than relying solely on reported financials. According to the post, gaps uncovered during diligence between operational revenue data and financial statements are influencing deal terms, lengthening diligence timelines, and in some cases contributing to deals not proceeding.

As shared in the post, this evolving focus effectively elevates revenue cycle management from a back-office function to a direct valuation driver, favoring practices with structured, auditable billing processes that appear more predictable and lower risk. For investors, this dynamic may imply a widening valuation spread between practices with robust revenue cycle controls and those with less mature infrastructure, potentially impacting roll‑up strategies and portfolio risk profiles.

The post indicates that CERTIFY Pay positions its platform as a tool to standardize how revenue is captured, validated, and tracked across the claim lifecycle, emphasizing traceable documentation and charge accuracy to withstand diligence scrutiny. If widely adopted, such solutions could support higher or more defensible valuation multiples for clients, and may place CERTIFY Pay in a favorable position to benefit from sustained private equity interest in physician practice consolidation and the growing emphasis on data integrity in healthcare transactions.